Sterneck Capital Management, LLC Gilead Sciences, Inc. Transaction History

Sterneck Capital Management, LLC

$179 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $43,290 - $48,757	750 Added 19.77%	4,544 $281,000
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $15,870 - $19,886	-274 Reduced 6.74%	3,794 $226,000
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $258,195 - $282,115	4,068 New	4,068 $285,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $212,028 - $246,204	-2,931 Closed	0 $0
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $2.05 Million - $2.62 Million	-32,686 Reduced 91.77%	2,931 $219,000
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $53,116 - $58,426	862 Added 2.48%	35,617 $2.31 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $58,384 - $64,446	-934 Reduced 2.62%	34,755 $2.2 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $88,659 - $99,421	-1,433 Reduced 3.86%	35,689 $2.41 Million
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $51,087 - $57,230	-817 Reduced 2.15%	37,122 $2.41 Million
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $248,698 - $324,532	-4,108 Reduced 9.77%	37,939 $2.37 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $320,617 - $354,982	-4,498 Reduced 9.66%	42,047 $3.25 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $352,493 - $411,169	-5,433 Reduced 10.45%	46,545 $3.3 Million
Q1 2018 Apr 12, 2018	SELL	$72.84 - $88.8 $296,385 - $361,327	-4,069 Reduced 7.26%	51,978 $3.92 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $317,186 - $372,332	-4,458 Reduced 7.37%	56,047 $4.02 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $394,658 - $467,777	-5,473 Reduced 8.3%	60,505 $4.9 Million
Q2 2017 Aug 16, 2017	BUY	N/A	65,978	65,978 $4.67 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterneck Capital Management, LLC with notifications on news.

Account